Literature DB >> 6354726

Hypertensive crisis treated with orally administered captopril.

J Biollaz, B Waeber, H R Brunner.   

Abstract

The value of the orally active converting enzyme inhibitor captopril in managing hypertensive crisis was tested in 9 untreated patients admitted to the emergency room, who were in need of rapid blood pressure reduction because of signs and symptoms of neurological and/or cardiac complications. During the 30 min following administration of captopril 25 mg the blood pressure decreased from 239/134 +/- 12/4 mmHg (mean +/- SEM) to 204/118 +/- 8/4 mmHg (p less than 0.05). From that time on, captopril 200 to 300 mg/day was continued for 2 to 5 days. In 5 patients furosemide in a total dose of 40 to 160 mg i.v. or p.o. had also to be given in order to control the blood pressure. 12 and 24 h after admission blood pressure averaged 140/93 and 139/86 mmHg respectively, in the patients treated with captopril alone, and 166/107 and 153/91 mmHg in those treated both with captopril and furosemide. The pronounced fall in blood pressure produced by blockade of the renin system was well tolerated and did not cause tachycardia. It appears, therefore, that captopril given alone or in association with a diuretic makes it possible to treat the hypertensive crisis without the need for monitoring in an intensive care unit.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354726     DOI: 10.1007/bf00543783

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

Review 1.  Renin, angiotensin and hypertensive vascular damage: a review.

Authors:  J Giese
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

2.  Oral minoxidil in the treatment of hypertensive crisis.

Authors:  B C Wood; J N Sharma; T T Crouch
Journal:  JAMA       Date:  1979-01-12       Impact factor: 56.272

3.  Treatment of hypertensive emergencies with oral labetalol.

Authors:  R R Ghose; Y B Mathur; M Upadhyay; W D Morgan; S Khan
Journal:  Br Med J       Date:  1978-07-08

4.  Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update.

Authors:  B Waeber; I Gavras; H R Brunner; H Gavras
Journal:  J Clin Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.126

5.  Oral clonidine loading in hypertensive urgencies.

Authors:  R J Anderson; G R Hart; C P Crumpler; W G Reed; C A Matthews
Journal:  JAMA       Date:  1981-08-21       Impact factor: 56.272

6.  A study on the effects of nifedipine in hypertensive crises and severe hypertension.

Authors:  I Kuwajima; K Ueda; C Kamata; S Matsushita; K Kuramoto; M Murakami; Y Hada
Journal:  Jpn Heart J       Date:  1978-07

7.  Converting enzyme inhibition in hypertensive emergencies.

Authors:  C P Tifft; H Gavras; G R Kershaw; I Gavras; H R Brunner; C S Liang; A V Chobanian
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

Review 8.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

9.  Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism.

Authors:  C S Liang; H Gavras
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

10.  A specific orally active inhibitor of angiotensin-converting enzyme in man.

Authors:  R K Ferguson; G A Turini; H R Brunner; H Gavras; D N McKinstry
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

View more
  7 in total

Review 1.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

Review 2.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

Review 3.  Treatment of hypertensive urgencies and emergencies.

Authors:  C Venkata S Ram; Russell L Silverstein
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

Review 4.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 5.  Hypertensive crises: emergencies and urgencies.

Authors:  Donald G Vidt
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-09       Impact factor: 3.738

Review 6.  Emergency room management of hypertensive urgencies and emergencies.

Authors:  D G Vidt
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 May-Jun       Impact factor: 3.738

7.  Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules.

Authors:  Cecilia B Michalowski; Marcelo D Arbo; Louise Altknecht; Andréia N Anciuti; Angélica S G Abreu; Luciana M R Alencar; Adriana R Pohlmann; Solange C Garcia; Sílvia S Guterres
Journal:  Pharmaceutics       Date:  2020-01-18       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.